All Publications for Health Care and Life Sciences


The TRIPS Agreement and Access to Health CarePublished Article
1999-09-01
By Dr. Richard Rozek with Nicola Tully
Patent Damages: Updated Rules On The Road To Economic RationalityReport
1999-01-01
By Dr. Phillip Beutel and Dr. Richard Rapp
Modern Methods For the Valuation of Intellectual PropertyReport
1998-11-01
By Drs. Richard Rapp and Lauren Stiroh
The Evidence Is In: A Review of the Market Definition Debate in Hospital Merger CasesPublished Article
1998-11-01
By Dr. Lawrence Wu
Regulatory Influences on the Decision to Introduce Pharmaceutical Products in JapanPublished Article
1998-09-01
By Dr. Richard Rapp and Dr. Richard Rozek with Gakushuin University Professor of Economics Tshuruhiko Nambu
The Effects of Patent Protection on the Prices of Pharmaceutical Products - Is IP Protection Raising the Drug Bill in Developing Countries?Published Article
1998-03-01
By Dr. Richard Rozek
Finding Patent Litigation Strategies That Make Economic Sense: What Does Your Client Really Need?Brief
1998-01-01
By Dr. Phillip Beutel
Applying the Best Method Rule When Reliable Internal Comparable Intangibles ExistPublished Article
1996-04-08
By Dr. Richard Rozek
Risk-Adjustment and Its Implications for Efficiency and Equity in Health Care SystemsReport
1996-01-01
By Dr. Thomas McCarthy with Keith Davies, John Gaisford and Ullrich Hoffmeyer
Analyzing Damages in Health Care Antitrust CasesWhite Paper
1995-04-03
By Dr. Thomas McCarthy and Dr. Scott Thomas